annual accounts payable:
$30.51M+$5.08M(+19.95%)Summary
- As of today (July 1, 2025), AMPH annual accounts payable is $30.51 million, with the most recent change of +$5.08 million (+19.95%) on December 31, 2024.
- During the last 3 years, AMPH annual accounts payable has risen by +$8.30 million (+37.36%).
- AMPH annual accounts payable is now -2.58% below its all-time high of $31.32 million, reached on December 31, 2018.
Performance
AMPH Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$52.81M+$22.30M(+73.08%)Summary
- As of today (July 1, 2025), AMPH quarterly accounts payable is $52.81 million, with the most recent change of +$22.30 million (+73.08%) on March 31, 2025.
- Over the past year, AMPH quarterly accounts payable has increased by +$16.28 million (+44.56%).
- AMPH quarterly accounts payable is now at all-time high.
Performance
AMPH quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMPH Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.9% | +44.6% |
| 3 y3 years | +37.4% | +121.5% |
| 5 y5 years | +21.8% | +220.0% |
AMPH Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.8% | at high | +180.4% |
| 5 y | 5-year | at high | +48.8% | at high | +180.4% |
| alltime | all time | -2.6% | +200.3% | at high | +450.7% |
AMPH Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $52.81M(+73.1%) |
| Dec 2024 | $30.51M(+20.0%) | $30.51M(-10.5%) |
| Sep 2024 | - | $34.09M(+7.3%) |
| Jun 2024 | - | $31.77M(-13.0%) |
| Mar 2024 | - | $36.53M(+43.6%) |
| Dec 2023 | $25.44M(+24.1%) | $25.44M(-20.4%) |
| Sep 2023 | - | $31.97M(+69.8%) |
| Jun 2023 | - | $18.83M(-14.3%) |
| Mar 2023 | - | $21.98M(+7.2%) |
| Dec 2022 | $20.50M(-7.7%) | $20.50M(+2.7%) |
| Sep 2022 | - | $19.96M(-35.8%) |
| Jun 2022 | - | $31.07M(+30.3%) |
| Mar 2022 | - | $23.84M(+7.3%) |
| Dec 2021 | $22.21M(-8.8%) | $22.21M(+2.6%) |
| Sep 2021 | - | $21.66M(-22.0%) |
| Jun 2021 | - | $27.75M(+20.7%) |
| Mar 2021 | - | $22.99M(-5.6%) |
| Dec 2020 | $24.36M(-2.8%) | $24.36M(+5.1%) |
| Sep 2020 | - | $23.17M(+6.7%) |
| Jun 2020 | - | $21.71M(+31.5%) |
| Mar 2020 | - | $16.51M(-34.1%) |
| Dec 2019 | $25.06M | $25.06M(+13.7%) |
| Sep 2019 | - | $22.04M(-29.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $31.46M(-8.2%) |
| Mar 2019 | - | $34.27M(+9.4%) |
| Dec 2018 | $31.32M(+88.4%) | $31.32M(+38.2%) |
| Sep 2018 | - | $22.67M(+4.6%) |
| Jun 2018 | - | $21.66M(+38.6%) |
| Mar 2018 | - | $15.63M(-6.0%) |
| Dec 2017 | $16.63M(-16.6%) | $16.63M(+73.4%) |
| Sep 2017 | - | $9.59M(-35.7%) |
| Jun 2017 | - | $14.91M(-22.8%) |
| Mar 2017 | - | $19.30M(-3.2%) |
| Dec 2016 | $19.93M(+43.7%) | $19.93M(+48.3%) |
| Sep 2016 | - | $13.44M(-28.4%) |
| Jun 2016 | - | $18.77M(+0.8%) |
| Mar 2016 | - | $18.62M(+34.2%) |
| Dec 2015 | $13.87M(+36.5%) | $13.87M(+13.1%) |
| Sep 2015 | - | $12.27M(-33.5%) |
| Jun 2015 | - | $18.45M(-2.6%) |
| Mar 2015 | - | $18.95M(+86.5%) |
| Dec 2014 | $10.16M(-50.1%) | $10.16M(+1.5%) |
| Sep 2014 | - | $10.01M(-43.6%) |
| Jun 2014 | - | $17.76M(+1.1%) |
| Mar 2014 | - | $17.57M(-13.8%) |
| Dec 2013 | $20.38M(+15.4%) | $20.38M |
| Dec 2012 | $17.66M | - |
FAQ
- What is Amphastar Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals annual accounts payable year-on-year change?
- What is Amphastar Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amphastar Pharmaceuticals?
- What is Amphastar Pharmaceuticals quarterly accounts payable year-on-year change?
What is Amphastar Pharmaceuticals annual accounts payable?
The current annual accounts payable of AMPH is $30.51M
What is the all time high annual accounts payable for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high annual accounts payable is $31.32M
What is Amphastar Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, AMPH annual accounts payable has changed by +$5.08M (+19.95%)
What is Amphastar Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of AMPH is $52.81M
What is the all time high quarterly accounts payable for Amphastar Pharmaceuticals?
Amphastar Pharmaceuticals all-time high quarterly accounts payable is $52.81M
What is Amphastar Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, AMPH quarterly accounts payable has changed by +$16.28M (+44.56%)